Assignee
GUANGDONG ZHONGSHENG PHARMACEUTICAL CO LTD
CN·6 granted patents·20 citations·filing 2015–2018
Top patents by PatentIndex Score
6 records- 0190US9938292B2Quinoline derivatives as SMO inhibitorsGUANGDONG ZHONGSHENG PHARMACEUTICAL CO LTD·Filed 2015·Granted Apr 10, 2018·19 cites·20 claims
- 0273US11008292B2FGFR4 inhibitor and preparation method and use thereofGUANGDONG ZHONGSHENG PHARMACEUTICAL CO LTD·Filed 2017·Granted May 18, 2021·1 cites·15 claims
- 0351US11440903B2Salt form and crystal form of compound as FGFR4 inhibitor and preparation method thereofGUANGDONG ZHONGSHENG PHARMACEUTICAL CO LTD·Filed 2018·Granted Sep 13, 2022·0 cites·26 claims
- 0451US10494373B2Fused-ring or tricyclic aryl pyrimidine compound used as kinase inhibitorGUANGDONG ZHONGSHENG PHARMACEUTICAL CO LTD·Filed 2016·Granted Dec 3, 2019·0 cites·13 claims
- 0544US10098885B2Hydroxyl purine compounds and applications thereofGUANGDONG ZHONGSHENG PHARMACEUTICAL CO LTD·Filed 2015·Granted Oct 16, 2018·0 cites·19 claims
- 0632US10532053B2Histone deacetylase inhibitor, and preparation method and use thereofGUANGDONG ZHONGSHENG PHARMACEUTICAL CO LTD·Filed 2016·Granted Jan 14, 2020·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when GUANGDONG ZHONGSHENG PHARMACEUTICAL CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →